| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.318 | 40.625 | 41.705 | 60.127 | 58.333 | 81.483 | 126.789 | 137.079 | 186.310 | 242.191 |
| Total Income - EUR | 5.318 | 40.625 | 41.705 | 60.155 | 69.728 | 81.483 | 126.789 | 153.480 | 210.525 | 288.960 |
| Total Expenses - EUR | 10.490 | 15.051 | 18.286 | 30.948 | 29.100 | 39.900 | 70.415 | 126.644 | 202.935 | 260.707 |
| Gross Profit/Loss - EUR | -5.172 | 25.573 | 23.419 | 29.207 | 40.627 | 41.583 | 56.374 | 26.837 | 7.590 | 28.254 |
| Net Profit/Loss - EUR | -5.331 | 24.355 | 21.871 | 27.402 | 38.536 | 40.224 | 55.106 | 25.332 | 5.577 | 20.457 |
| Employees | 0 | 1 | 1 | 0 | 1 | 1 | 2 | 2 | 4 | 4 |
Check the financial reports for the company - Raymedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.868 | 10.378 | 43.652 | 37.026 | 33.095 | 25.654 | 20.566 | 83.474 | 264.717 | 222.177 |
| Current Assets | 1.969 | 3.500 | 31.032 | 53.121 | 37.823 | 57.289 | 74.929 | 30.918 | 26.691 | 56.691 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 87 | 0 | 255 | 1.047 | 0 |
| Receivables | 26 | 2.337 | 29.301 | 52.689 | 35.445 | 56.622 | 68.085 | 28.426 | 23.193 | 55.568 |
| Cash | 1.943 | 1.163 | 1.730 | 432 | 2.378 | 579 | 6.844 | 2.237 | 2.451 | 1.124 |
| Shareholders Funds | -11.168 | 13.301 | 34.947 | 54.400 | 38.713 | 40.397 | 55.276 | 25.502 | 5.949 | 20.626 |
| Social Capital | 157 | 156 | 153 | 150 | 148 | 145 | 142 | 142 | 142 | 141 |
| Debts | 25.004 | 577 | 39.736 | 35.807 | 32.205 | 42.546 | 40.219 | 98.339 | 99.227 | 97.555 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 190.707 | 165.908 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Raymedica Srl